Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing
OO Glebov - The FEBS journal, 2020 - Wiley Online Library
The quest for the effective treatment against coronavirus disease 2019 pneumonia caused
by the severe acute respiratory syndrome (SARS)‐coronavirus 2 (CoV‐2) coronavirus is …
by the severe acute respiratory syndrome (SARS)‐coronavirus 2 (CoV‐2) coronavirus is …
Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing.
OO Glebov - 2020 - cabidigitallibrary.org
The quest for the effective treatment against coronavirus disease 2019 pneumonia caused
by the severe acute respiratory syndrome (SARS)-coronavirus 2 (CoV-2) coronavirus is …
by the severe acute respiratory syndrome (SARS)-coronavirus 2 (CoV-2) coronavirus is …
[引用][C] Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing
OO Glebov - The FEBS Journal, 2020 - cir.nii.ac.jp
Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
[PDF][PDF] Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing
OO Glebov - scienceopen.com
The quest for the effective treatment against coronavirus disease 2019 pneumonia caused
by the severe acute respiratory syndrome (SARS)-coronavirus 2 (CoV-2) coronavirus is …
by the severe acute respiratory syndrome (SARS)-coronavirus 2 (CoV-2) coronavirus is …
[PDF][PDF] Understanding the cell biology of SARS-CoV-2 endocytosis for COVID-19 drug repurposing: looking beyond chloroquine
OO Glebov - scholar.archive.org
The quest for the effective treatment against COVID-19 pneumonia caused by the SARS-
CoV-2 coronavirus is hampered by the lack of knowledge concerning the basic cell biology …
CoV-2 coronavirus is hampered by the lack of knowledge concerning the basic cell biology …
Understanding the cell biology of SARS-CoV-2 endocytosis for COVID-19 drug repurposing: looking beyond chloroquine
O Glebov - osf.io
The quest for the effective treatment against COVID-19 pneumonia caused by the SARS-
CoV-2 coronavirus is hampered by the lack of knowledge concerning the basic cell biology …
CoV-2 coronavirus is hampered by the lack of knowledge concerning the basic cell biology …
Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing.
OO Glebov - The FEBS Journal, 2020 - europepmc.org
The quest for the effective treatment against coronavirus disease 2019 pneumonia caused
by the severe acute respiratory syndrome (SARS)‐coronavirus 2 (CoV‐2) coronavirus is …
by the severe acute respiratory syndrome (SARS)‐coronavirus 2 (CoV‐2) coronavirus is …
[HTML][HTML] Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing
OO Glebov - The Febs Journal, 2020 - ncbi.nlm.nih.gov
The quest for the effective treatment against coronavirus disease 2019 pneumonia caused
by the severe acute respiratory syndrome (SARS)‐coronavirus 2 (CoV‐2) coronavirus is …
by the severe acute respiratory syndrome (SARS)‐coronavirus 2 (CoV‐2) coronavirus is …
Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing
OO Glebov - The FEBS journal, 2020 - pubmed.ncbi.nlm.nih.gov
The quest for the effective treatment against coronavirus disease 2019 pneumonia caused
by the severe acute respiratory syndrome (SARS)-coronavirus 2 (CoV-2) coronavirus is …
by the severe acute respiratory syndrome (SARS)-coronavirus 2 (CoV-2) coronavirus is …
Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing
OO Glebov - FEBS Journal, 2020 - kclpure.kcl.ac.uk
The quest for the effective treatment against coronavirus disease 2019 pneumonia caused
by the severe acute respiratory syndrome (SARS)-coronavirus 2 (CoV-2) coronavirus is …
by the severe acute respiratory syndrome (SARS)-coronavirus 2 (CoV-2) coronavirus is …